Adenoviral (Ad) Vector Platform for CAR Transduction

Online Inquiry

Background Platforms What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides an Adenoviral (Ad) Vector Platform for CAR Transduction to accelerate CAR construct validation and immune cell engineering workflows. This platform addresses challenges such as lengthy plasmid-to-lentivirus optimization cycles, payload size limitations for complex CAR designs, and concerns associated with random genomic integration during early-stage screening. Through non-integrating episomal delivery, broad tropism, and high payload capacity, Creative Biolabs enables efficient evaluation of CAR functionality, novel scFv screening, and engineering of diverse immune cell types, including CAR-T, CAR-NK, and CAR-M platforms for preclinical research.

Introduction

Recombinant adenoviruses (rAd) have evolved from classical gene replacement vehicles into indispensable tools for immune cell engineering. Operating through transient, episomal expression without host genome integration, Ad vectors eliminate random insertion risks while providing unmatched payload capacities. Recent literature confirms that transient CAR delivery mediated by adenoviral platforms facilitates rapid functional screening, precise toxicity profiling, and robust transduction in hard-to-engineer cells like macrophages. Creative Biolabs leverages these unique capabilities to deliver scalable, reliable CAR transduction platforms for global biopharmaceutical researchers.

Our Platforms

At Creative Biolabs, our specialized Adenoviral (Ad) Vector Platform acts as a rapid prototyping engine for cell therapy developers. Before committing substantial budget and time to permanent integrating platforms like lentivirus, our platform provides a high-throughput, non-integrating avenue to test, optimize, and validate your chimeric antigen receptors.

Key Capabilities & Solutions:

Accelerated Lead Candidate Screening: Evaluate multiple scFv affinities, hinge lengths, and costimulatory domain combinations in parallel without the delay of stable cell line generation.
Large & Multi-Gene Payload Handling: Seamlessly package complex genetic architectures, including dual-CARs, logic gates (AND/OR), safety switches, and armored cytokine cassettes.
High Efficiency across Diverse Lineages: Achieve near 100% transient transduction in primary T cells, NK cells, and hard-to-transduce myeloid lineages.
Zero Insertional Mutagenesis Risk: Maintain target genes in an episomal state, ensuring predictable, transient expression profiles optimal for safety evaluations and toxicity assessments.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Platform of Adenoviral (Ad) Vector Platform for CAR Transduction. (Creative Biolabs Original)

Creative Biolabs delivers recombinant adenoviral vector systems for CAR cell construction, payload packaging, and functional assessment. Its platforms include 7.5 kb-capacity E1/E3-deleted first-gen vectors, gutless helper-dependent "gutless" adenovirus holding up to 36 kb for complex multi-gene circuits, pseudotyped capsids to bypass immunity, and custom logic-gate expression cassettes. These tools enable fast CAR-T prototyping and efficient transduction of primary NK and macrophages for CAR-NK/CAR-M development.

Our Workflow

Clients are expected to provide CAR construct sequences, target antigen information, and therapeutic design requirements, along with vector designs, expression cassettes, and relevant molecular data. Please also share details of target cells, disease indications, intended biological outcomes, preclinical objectives, evaluation criteria, and supporting experimental data.

Workflow of Adenoviral (Ad) Vector Platform for CAR Transduction. (Creative Biolabs Original)

Upon project completion, you will obtain a cryopreserved high-purity recombinant adenoviral vector with certified titers, a full CoA covering multiple quality indicators, and a transduced cell characterization report with flow, copy number, and functional data.

Benefits

Decades of Specialized Expertise: Over 20 years of experience in viral vector design, primary cell transduction, and complex synthetic biology applications.
Fully Tailored & Flexible Service: Every project is fully customizable, from vector backbone selection and fiber modifications to personalized assay design.
Unrivaled Payload Versatility: Ability to package simple scFv constructs or massive 36 kb multi-gene circuits that fail in other viral systems.

FAQs

Q1: Why should I choose adenoviral vectors over lentiviral vectors during early-stage CAR screening?

A1: Adenoviral vectors provide a non-integrating, episomal delivery mode that yields rapid, high-level surface expression without requiring stable genomic integration. This makes them substantially faster and more cost-effective for screening multiple candidate constructs before committing to costly lentiviral manufacturing.

Q2: What is the advantage of adenoviral vectors for complex CAR constructs?

A2: With large cargo capacity (~7.5 kb for E1/E3-deleted Ad and up to ~36 kb for HDAd), adenoviral vectors support multi-CAR circuits, cytokines, and safety switches.

Q3: How does Creative Biolabs improve adenoviral transduction of primary immune cells?

A3: By using engineered capsids, Creative Biolabs enhances targeting and transduction efficiency in CAR-T, CAR-NK, and other immune cells.

Partner with Us

Creative Biolabs provides an integrated Adenoviral (Ad) Vector Platform for CAR Transduction, helping global biopharmaceutical partners accelerate their cell therapy pipelines. From rapid scFv structural screening and high-capacity helper-dependent vector packaging to tropism-engineered pseudotyping and complete in vitro functional characterization, Creative Biolabs serves as a trusted partner in next-generation cell therapy research. Ready to accelerate your CAR development project with our high-efficiency adenoviral delivery platforms? Contact us to connect with our seasoned bioprocess scientists and project coordinators, who will work with you to align custom vector designs and technical timelines with your unique experimental objectives.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.